Skip to content

Study of Blood Samples From Patients With Ewing Sarcoma and Their Relatives

GENEWING - A Genome Wide Association Study in Ewing Sarcoma

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01210209
Acronym
GENEWING
Enrollment
350
Registered
2010-09-28
Start date
2010-01-07
Completion date
2019-07-31
Last updated
2021-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcoma

Keywords

Ewing sarcoma, Ewing sarcoma/peripheral primitive neuroectodermal tumor (PNET)

Brief summary

RATIONALE: Studying samples of blood in the laboratory from patients with cancer and their relatives may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is looking at blood samples collected from patients with Ewing sarcoma and their relatives.

Detailed description

OBJECTIVES: * To identify and characterize a genetic susceptibility factor to Ewing's sarcoma by performing a Genome-Wide Association Study with as many as possible Ewing sarcoma patients. OUTLINE: This is a multicenter study. Blood samples are collected from patients and their relatives. Blood DNA samples are analyzed for susceptibility genes of Ewing Sarcoma.

Interventions

Sponsors

Institut Curie
Lead SponsorOTHER

Study design

Observational model
FAMILY_BASED
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
0 Years to 120 Years
Healthy volunteers
Yes

Inclusion criteria

DISEASE CHARACTERISTICS: * Patients with Ewing sarcoma * Relatives of Ewing sarcoma patients PATIENT CHARACTERISTICS: * Patients with a fusion genes specific of Ewing Sarcoma PRIOR CONCURRENT THERAPY: * Not applicable

Design outcomes

Primary

MeasureTime frameDescription
Identification and characterization of susceptibility genes in patients with Ewing sarcomaThrough study completion, an average of 10 yearsIdentification and characterization of susceptibility genes in patients with Ewing sarcoma

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026